State Street Corp Oramed Pharmaceuticals Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, State Street Corp holds 59,260 shares of ORMP stock, worth $137,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,260
Previous 58,132
1.94%
Holding current value
$137,483
Previous $169,000
10.06%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ORMP
# of Institutions
61Shares Held
6.36MCall Options Held
0Put Options Held
0-
Murchinson Ltd. Toronto, A61.7MShares$3.94 Million0.77% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.35MShares$3.13 Million2.47% of portfolio
-
Boothbay Fund Management, LLC New York, NY825KShares$1.91 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$850,0502.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$672,3420.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $90.1M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...